W. Wolfgang Fleischhacker, Alex Hofer, Christian Jagsch, Walter Pirker, Georg Psota: Antipsychotikainduzierte tardive Syndrome. In: neuropsychiatrie. Band30, Nr.3, 1. September 2016, ISSN2194-1327, S.123–130, doi:10.1007/s40211-016-0189-7.
google.de
books.google.de
Karl F. Masuhr: Extrapyramidale Hyperkinesen: ein Leitfaden für Klinik und Praxis. Seite 127. Georg Thieme Verlag, 2000, ISBN 3-13-105601-0 (eingeschränkte Vorschau in der Google-Buchsuche).
David R. Hawkins: The prevention of Tardive Dyskinesia with high dosage vitamins: A study of 58,000 patients. In: Journal of Orthomolecular Medicine. Band1, Nr.1, 1986, S.24–26 (englisch, orthomolecular.org [PDF; abgerufen am 16. Dezember 2019]). “A study of the practices of 80 physicians over a 10 year caseload of 58,000 patients treated with anti-psychotic drugs plus high dosage vitamins, reveals a total of only 26 patients developing Tardive Dyskinesia. This is an incidence of less than 0.05%. This is a remarkable finding in view of currently reported rates of 10% to as high as 60%. The data are strongly suggestive that the prescribing of high dosage Vitamins B3, C and B6, along with neuroleptic drugs, provides almost 100% protection against the development of this dread neurological disorder which is reportedly irreversible in 50% of those patients in whom it develops.”
W. Wolfgang Fleischhacker, Alex Hofer, Christian Jagsch, Walter Pirker, Georg Psota: Antipsychotikainduzierte tardive Syndrome. In: neuropsychiatrie. Band30, Nr.3, 1. September 2016, ISSN2194-1327, S.123–130, doi:10.1007/s40211-016-0189-7.